249 related articles for article (PubMed ID: 7589072)
41. The immune response and the eye. II. The nature of T suppressor cell induction in anterior chamber-associated immune deviation (ACAID).
Ferguson TA; Waldrep JC; Kaplan HJ
J Immunol; 1987 Jul; 139(2):352-7. PubMed ID: 2955039
[TBL] [Abstract][Full Text] [Related]
42. The immune response and the eye. TCR alpha-chain related molecules regulate the systemic immunity to antigen presented in the eye.
Griffith TS; Herndon JM; Lima J; Kahn M; Ferguson TA
Int Immunol; 1995 Oct; 7(10):1617-25. PubMed ID: 8562507
[TBL] [Abstract][Full Text] [Related]
43. Requirement for splenic CD4+ T cells in the immune privilege of the anterior chamber of the eye.
Takahashi M; Ishimaru N; Yanagi K; Saegusa K; Haneji N; Shiota H; Hayashi Y
Clin Exp Immunol; 1999 May; 116(2):231-7. PubMed ID: 10337012
[TBL] [Abstract][Full Text] [Related]
44. Effects of human umbilical cord-derived mesenchymal stem cells on anterior chamber-associated immune deviation.
Zhang Y; Zhang M; Zhao S; Li X; Jia Z; Zhang L; Han ZC; Zhang X
Int Immunopharmacol; 2013 Jan; 15(1):114-20. PubMed ID: 23178576
[TBL] [Abstract][Full Text] [Related]
45. Lymphoma allografts abrogate immune privilege within the anterior chamber of the eye.
Niederkorn JY; Streilein JW
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1235-43. PubMed ID: 3089965
[TBL] [Abstract][Full Text] [Related]
46. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
Yamada J; Zhu SN; Streilein JW; Dana MR
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
[TBL] [Abstract][Full Text] [Related]
47. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
Yamada J; Streilein JW
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
[TBL] [Abstract][Full Text] [Related]
48. Gamma delta T cells are needed for ocular immune privilege and corneal graft survival.
Skelsey ME; Mellon J; Niederkorn JY
J Immunol; 2001 Apr; 166(7):4327-33. PubMed ID: 11254685
[TBL] [Abstract][Full Text] [Related]
49. Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye.
Hara Y; Caspi RR; Wiggert B; Dorf M; Streilein JW
J Immunol; 1992 Sep; 149(5):1531-8. PubMed ID: 1387141
[TBL] [Abstract][Full Text] [Related]
50. Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival.
Niederkorn JY; Mayhew E; Mellon J; Hegde S
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2674-81. PubMed ID: 15277491
[TBL] [Abstract][Full Text] [Related]
51. Splenic B cells act as antigen presenting cells for the induction of anterior chamber-associated immune deviation.
Skelsey ME; Mayhew E; Niederkorn JY
Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5242-51. PubMed ID: 14638723
[TBL] [Abstract][Full Text] [Related]
52. Anterior chamber-associated immune deviation induced by TNP-splenocytes (TNP-ACAID). II. Suppressor T-cell networks.
Waldrep JC; Kaplan HJ
Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1339-45. PubMed ID: 6225745
[TBL] [Abstract][Full Text] [Related]
53. Effect of anterior chamber-associated immune deviation (ACAID) on rat islet allograft rejection.
Koevary SB; Beaudry K
Ocul Immunol Inflamm; 2000 Mar; 8(1):39-47. PubMed ID: 10806433
[TBL] [Abstract][Full Text] [Related]
54. Anterior chamber-associated immune deviation.
Biros D
Vet Clin North Am Small Anim Pract; 2008 Mar; 38(2):309-21, vi-vii. PubMed ID: 18299009
[TBL] [Abstract][Full Text] [Related]
55. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta.
Wilbanks GA; Streilein JW
Eur J Immunol; 1992 Apr; 22(4):1031-6. PubMed ID: 1551403
[TBL] [Abstract][Full Text] [Related]
56. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye.
Streilein JW
Eye (Lond); 1995; 9 ( Pt 2)():236-40. PubMed ID: 7556724
[TBL] [Abstract][Full Text] [Related]
57. Direct thymic involvement in anterior chamber-associated immune deviation: evidence for a nondeletional mechanism of centrally induced tolerance to extrathymic antigens in adult mice.
Wang Y; Goldschneider I; Foss D; Wu DY; O'Rourke J; Cone RE
J Immunol; 1997 Mar; 158(5):2150-5. PubMed ID: 9036960
[TBL] [Abstract][Full Text] [Related]
58. Studies on the induction of tolerance to alloantigens. I. The abrogation of potentials for delayed-type-hypersensitivity response to alloantigens by portal venous inoculation with allogeneic cells.
Qian J; Hashimoto T; Fujiwara H; Hamaoka T
J Immunol; 1985 Jun; 134(6):3656-61. PubMed ID: 2580893
[TBL] [Abstract][Full Text] [Related]
59. T-cell-mediated immune responses in alloepithelial rejection after murine keratoepithelioplasty.
Miyazaki D; Inoue Y; Yao YF; Okada AA; Shimomura Y; Hayashi K; Tano Y; Ohashi Y
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2590-7. PubMed ID: 10509654
[TBL] [Abstract][Full Text] [Related]
60. [The role of spleen in induction and maintenance of anterior chamber-associated immune deviation in different species of animals].
Li Z; Peng G; Li C
Yan Ke Xue Bao; 1999 Dec; 15(4):221-4, 237. PubMed ID: 12579673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
